01.11.2022 | Case report
Certolizumab-pegol/methotrexate/tocilizumab
Lack of efficacy and urticarial drug eruption: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2022
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event